Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease

被引:0
|
作者
Mohs, RC
Schmeidler, J
Aryan, M
机构
[1] Mt Sinai Sch Med, VA Med Ctr, Res Serv 151, Bronx, NY 10468 USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Dept Biomath Sci, New York, NY 10029 USA
关键词
D O I
10.1002/(SICI)1097-0258(20000615/30)19:11/12<1401::AID-SIM432>3.0.CO;2-X
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This paper reviews data on the natural history of symptoms in patients with Alzheimer's disease (AD) and describes some of the problems encountered in analysing longitudinal data in this population. Data on cognition, functional ability and psychiatric or behavioural symptoms have all been obtained from AD patients. Because of attrition, the length of follow-up is not uniform for all patients and neither is the frequency of evaluation, Furthermore, patients enter longitudinal studies with a wide range of symptom severity and longitudinal decline in cognition and function is distinctly non-linear. Behavioural symptoms do not progress regularly in AD but are episodic phenomena not closely related to cognition or function. Strengths and limitations of various analytic techniques used for hypothesis testing with these longitudinal data are described. Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:1401 / 1409
页数:9
相关论文
共 50 条
  • [41] Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease
    de Oliveira, Fabricio Ferreira
    de Almeida, Sandro Soares
    Chen, Elizabeth Suchi
    Smith, Marilia Cardoso
    Naffah-Mazzacoratti, Maria da Graca
    Ferreira Bertolucci, Paulo Henrique
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 65 (04) : 1283 - 1299
  • [42] Functional deficits in patients with mild cognitive impairment: Prediction of Alzheimer's disease
    Tabert, MH
    Albert, SM
    Pelton, GH
    Devanand, DP
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 183S - 184S
  • [43] Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease
    Francis, Paul T.
    NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) : 241 - 243
  • [44] Cerebrovascular disease, Alzheimer's disease biomarkers and longitudinal cognitive decline
    Yates, P. A.
    Villemagne, V. L.
    Ames, D.
    Masters, C. L.
    Martins, R. N.
    Desmond, P.
    Burnham, S.
    Maruff, P.
    Ellis, K. A.
    Rowe, C. C.
    AUSTRALASIAN JOURNAL ON AGEING, 2016, 35 : 18 - 19
  • [45] Longitudinal Analysis of Fractional Anisotropy in Patients With Mild Cognitive Impairment and Alzheimer's Disease
    Nowrangi, Milap A.
    Mielke, Michelle
    Oishi, Kenichi
    Smith, Gwenn
    Albert, Marilyn
    Mori, Susumu
    Lyketsos, Constantine G.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 23 (02) : 17 - 17
  • [46] Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study
    Livingston, G.
    Walker, A. E.
    Katona, C. L. E.
    Cooper, C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (01): : 25 - 29
  • [47] Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies
    Carpi, Matteo
    Fernandes, Mariana
    Mercuri, Nicola Biagio
    Liguori, Claudio
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (01) : 121 - 143
  • [48] Predictors of cognitive and functional decline in Alzheimer's disease
    Mungas, D
    Reed, BR
    Jagust, WJ
    NEUROLOGY, 1999, 52 (06) : A436 - A437
  • [49] Longitudinal amyloid cognitive composite in preclinical Alzheimer's disease
    Kim, Young Ju
    Hahn, Alice
    Park, Yu Hyun
    Na, Duk L.
    Chin, Juhee
    Seo, Sang Won
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (04) : 980 - 989
  • [50] Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
    Uretsky, Madeline
    Gibbons, Laura E.
    Mukherjee, Shubhabrata
    Trittschuh, Emily H.
    Fardo, David W.
    Boyle, Patricia A.
    Keene, C. Dirk
    Saykin, Andrew J.
    Crane, Paul K.
    Schneider, Julie A.
    Mez, Jesse
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2021, 7 (01)